Company profile for BioMarin Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

With seven products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs. At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission�...
With seven products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs. At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission—to bring new treatments to market that will make a big impact on small patient populations.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
770 Lindaro Street San Rafael, CA 94901
Telephone
Telephone
415-506-6700
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079

FDA
20 Nov 2025

https://www.prnewswire.com/news-releases/biomarin-to-participate-at-the-jefferies-global-healthcare-conference-on-tuesday-november-18-2025-at-1030-am-gmt-in-london-england-302610867.html

PR NEWSWIRE
11 Nov 2025

https://www.prnewswire.com/news-releases/fda-accepts-biomarins-palynziq-pegvaliase-pqpz-supplemental-biologics-license-application-for-priority-review-to-expand-use-to-adolescents-aged-12-17-with-phenylketonuria-302597628.html

PR NEWSWIRE
29 Oct 2025

https://www.prnewswire.com/news-releases/biomarin-reports-third-quarter-2025-results-and-provides-corporate-update-302595620.html

PR NEWSWIRE
27 Oct 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/biomarin-pharma-plans-divest-struggling-gene-therapy-2025-10-27/

REUTERS
27 Oct 2025

https://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2025-financial-results-conference-call-and-webcast-on-monday-october-27-2025-at-430pm-et-302590758.html

PR NEWSWIRE
22 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty